Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France
Abstract
Authors
G Sroczynski A Conrads-Frank N Mühlberger F Kühne G Jeanblanc JC Samp I Durand-Zaleski U Siebert